These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36466927)

  • 1. Neutralizing epitopes on
    Chen B; Perry K; Jin R
    Front Immunol; 2022; 13():978858. PubMed ID: 36466927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.
    Kordus SL; Kroh HK; Rodríguez RC; Shrem RA; Peritore-Galve FC; Shupe JA; Wadzinski BE; Lacy DB; Spiller BW
    PLoS Pathog; 2023 Oct; 19(10):e1011496. PubMed ID: 37871122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
    Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
    Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of
    Raeisi H; Azimirad M; Asadzadeh Aghdaei H; Zarnani AH; Abdolalizadeh J; Yadegar A; Zali MR
    Microbiol Spectr; 2023 Sep; 11(5):e0531022. PubMed ID: 37668373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxification of toxin A and toxin B by copper ion-catalyzed oxidation in production of a toxoid-based vaccine against Clostridioides difficile.
    Aminzadeh A; Tiwari MK; Mamah Mustapha SS; Navarrete SJ; Henriksen AB; Møller IM; Krogfelt KA; Bjerrum MJ; Jørgensen R
    Free Radic Biol Med; 2020 Nov; 160():433-446. PubMed ID: 32860983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of
    Fühner V; Heine PA; Helmsing S; Goy S; Heidepriem J; Loeffler FF; Dübel S; Gerhard R; Hust M
    Front Microbiol; 2018; 9():2908. PubMed ID: 30574127
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant.
    Aminzadeh A; Hilgers L; Paul Platenburg P; Riou M; Perrot N; Rossignol C; Cauty A; Barc C; Jørgensen R
    Vaccine; 2024 Mar; 42(7):1582-1592. PubMed ID: 38336558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.
    Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar RH; Mikelsaar M; Verrips T; Hammarström L; Marcotte H
    Infect Immun; 2016 Feb; 84(2):395-406. PubMed ID: 26573738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab.
    Hernandez LD; Kroh HK; Hsieh E; Yang X; Beaumont M; Sheth PR; DiNunzio E; Rutherford SA; Ohi MD; Ermakov G; Xiao L; Secore S; Karczewski J; Racine F; Mayhood T; Fischer P; Sher X; Gupta P; Lacy DB; Therien AG
    J Mol Biol; 2017 Apr; 429(7):1030-1044. PubMed ID: 28232034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and conformational dynamics of
    Chen B; Basak S; Chen P; Zhang C; Perry K; Tian S; Yu C; Dong M; Huang L; Bowen ME; Jin R
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35292538
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.
    Yang Z; Schmidt D; Liu W; Li S; Shi L; Sheng J; Chen K; Yu H; Tremblay JM; Chen X; Piepenbrink KH; Sundberg EJ; Kelly CP; Bai G; Shoemaker CB; Feng H
    J Infect Dis; 2014 Sep; 210(6):964-72. PubMed ID: 24683195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing antibody that blocks delivery of the enzymatic cargo of
    Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
    J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
    Wang S; Zhu D; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
    J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
    Chen B; Liu Z; Perry K; Jin R
    Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.
    Murase T; Eugenio L; Schorr M; Hussack G; Tanha J; Kitova EN; Klassen JS; Ng KK
    J Biol Chem; 2014 Jan; 289(4):2331-43. PubMed ID: 24311789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on
    Martínez-Meléndez A; Cruz-López F; Morfin-Otero R; Maldonado-Garza HJ; Garza-González E
    Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
    Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
    J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.